In the present cross‐sectional study, the serum anti‐EA IgA and IgG levels of 46 screened NPC patients and 263 non‐NPC participants with elevated EBNA1/IgA and VCA/IgA in the screening program and confirmed as negative by endoscopy were determined. Here, CD79A is linked to nasopharyngeal carcinoma.